Insider Stock Trading History of Fust Matthew K


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Fust Matthew K since year 2005. The trader's CIK number is 1397266. At the time of this reporting, Fust Matthew K is the Director of Atara Biotherapeutics, Inc. . (stock ticker symbol ATRA). See this page for all insider trading activities at Atara Biotherapeutics, Inc. .

Note that in the past Fust Matthew K also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Fust Matthew K since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-15 ATRA Atara Biotherapeutics, Inc. Option Ex 1,602 .00 0
2017-08-15 ATRA Atara Biotherapeutics, Inc. Option Ex 1,603 .00 0
2017-05-15 ATRA Atara Biotherapeutics, Inc. Option Ex 1,602 .00 0
2017-02-15 ATRA Atara Biotherapeutics, Inc. Option Ex 1,603 .00 0
2016-11-15 ATRA Atara Biotherapeutics, Inc. Option Ex 1,602 .00 0
2016-08-15 ATRA Atara Biotherapeutics, Inc. Option Ex 1,603 .00 0
2016-05-16 ATRA Atara Biotherapeutics, Inc. Option Ex 1,602 .00 0
2016-02-16 ATRA Atara Biotherapeutics, Inc. Option Ex 1,603 .00 0
2015-11-16 ATRA Atara Biotherapeutics, Inc. Option Ex 1,602 .00 0
2015-08-17 ATRA Atara Biotherapeutics, Inc. Option Ex 1,603 .00 0
2015-06-29 DERM Dermira, Inc. Option Ex 9,051 5.51 49,871
2015-05-15 ATRA Atara Biotherapeutics, Inc. Option Ex 7,478 .00 0
2015-03-19 RARE Ultragenyx Pharmaceutical Inc. Option Ex 6,319 21.00 132,699
2014-11-25 DERM Dermira, Inc. Buy 6,000 16.77 100,602
2014-01-30 RARE Ultragenyx Pharmaceutical Inc. Buy 5,000 21.00 105,000
2013-08-08 ONXX Onyx Pharmaceuticals Inc Sale 2,492 128.21 319,499
2013-07-26 ONXX Onyx Pharmaceuticals Inc Sale 6,043 130.50 788,611
2013-07-02 ONXX Onyx Pharmaceuticals Inc Sale 1,551 132.80 205,972
2013-05-13 ONXX Onyx Pharmaceuticals Inc Sale 10,269 98.12 1,007,594
2013-05-13 ONXX Onyx Pharmaceuticals Inc Option Ex 10,269 34.48 354,075
2013-04-15 ONXX Onyx Pharmaceuticals Inc Sale 1,347 95.15 128,167
2013-04-01 ONXX Onyx Pharmaceuticals Inc Sale 3,861 86.14 332,567
2013-03-05 ONXX Onyx Pharmaceuticals Inc Option Ex 2,211 34.48 76,235
2013-02-28 ONXX Onyx Pharmaceuticals Inc Sale 15,000 77.12 1,156,800
2013-02-28 ONXX Onyx Pharmaceuticals Inc Option Ex 10,000 34.48 344,799
2013-01-10 ONXX Onyx Pharmaceuticals Inc Option Ex 7,112 34.48 245,221
2013-01-10 ONXX Onyx Pharmaceuticals Inc Sale 10,199 85.12 868,138
2012-11-28 ONXX Onyx Pharmaceuticals Inc Option Ex 966 34.48 33,307
2012-08-06 ONXX Onyx Pharmaceuticals Inc Sale 22,009 71.77 1,579,519
2012-08-06 ONXX Onyx Pharmaceuticals Inc Option Ex 17,492 34.48 603,124
2012-07-25 ONXX Onyx Pharmaceuticals Inc Sale 5,207 73.97 385,172
2012-03-02 ONXX Onyx Pharmaceuticals Inc Sale 592 37.52 22,211
2012-02-14 ONXX Onyx Pharmaceuticals Inc Option Ex 5,000 34.48 172,399
2012-01-06 ONXX Onyx Pharmaceuticals Inc Sale 1,789 43.46 77,749
2011-11-18 ONXX Onyx Pharmaceuticals Inc Sale 867 38.05 32,989
2011-04-01 ONXX Onyx Pharmaceuticals Inc Sale 800 35.02 28,016
2011-01-06 ONXX Onyx Pharmaceuticals Inc Sale 1,812 37.28 67,551
2010-01-06 ONXX Onyx Pharmaceuticals Inc Sale 1,919 29.60 56,802

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fust Matthew K (Director of Atara Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.